Open clinical trial, controlled for the evaluation of the efficacy and safety of using Nimotuzumab in patients with triple-negative breast cancer. Phase II / III.
Phase of Trial: Phase II/III
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Cyclophosphamide
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 29 Aug 2016 New trial record